These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 2699170)
1. Co-expression of CA 19-9, DU-PAN-2, CA 125, and TAG-72 in pancreatic adenocarcinoma. Tempero M; Takasaki H; Uchida E; Takiyama Y; Colcher D; Metzgar RS; Pour PM Am J Surg Pathol; 1989; 13 Suppl 1():89-95. PubMed ID: 2699170 [TBL] [Abstract][Full Text] [Related]
2. Correlative study on expression of CA 19-9 and DU-PAN-2 in tumor tissue and in serum of pancreatic cancer patients. Takasaki H; Uchida E; Tempero MA; Burnett DA; Metzgar RS; Pour PM Cancer Res; 1988 Mar; 48(6):1435-8. PubMed ID: 3162196 [TBL] [Abstract][Full Text] [Related]
3. Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer. Tempero MA; Uchida E; Takasaki H; Burnett DA; Steplewski Z; Pour PM Cancer Res; 1987 Oct; 47(20):5501-3. PubMed ID: 3308077 [TBL] [Abstract][Full Text] [Related]
4. Comparative studies on the expression of tumor-associated glycoprotein (TAG-72), CA 19-9 and DU-PAN-2 in normal, benign and malignant pancreatic tissue. Takasaki H; Tempero MA; Uchida E; Büchler M; Ness MJ; Burnett DA; Metzgar RS; Colcher D; Schlom J; Pour PM Int J Cancer; 1988 Nov; 42(5):681-6. PubMed ID: 3053465 [TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of serum DU-PAN-2 surveyed by solid-phase sandwich EIA for DU-PAN-2]. Ishii M; Urabe T; Seino Y Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1860-5. PubMed ID: 3296960 [TBL] [Abstract][Full Text] [Related]
6. Tumor markers in pancreatic cancer--current concepts. Schmiegel W Hepatogastroenterology; 1989 Dec; 36(6):446-9. PubMed ID: 2693300 [TBL] [Abstract][Full Text] [Related]
7. The patterns of coexpression of tumor-associated antigens CA 19-9, TAG-72, and DU-PAN-2 in human pancreatic cancer. Toshkov I; Mogaki M; Kazakoff K; Pour PM Int J Pancreatol; 1994 Apr; 15(2):97-103. PubMed ID: 8071575 [TBL] [Abstract][Full Text] [Related]
8. [Detection of DU-PAN-2 antigen (pancreatic cancer-associated antigen) in sera of patients with cancer of the digestive tract]. Takami H; Furuuchi T; Ogata Y; Abe O Gan To Kagaku Ryoho; 1986 Oct; 13(11):3207-14. PubMed ID: 3777958 [TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibodies against human pancreatic adenocarcinoma: distribution of DU-PAN-2 antigen on glandular epithelia and adenocarcinomas. Borowitz MJ; Tuck FL; Sindelar WF; Fernsten PD; Metzgar RS J Natl Cancer Inst; 1984 May; 72(5):999-1005. PubMed ID: 6371347 [TBL] [Abstract][Full Text] [Related]
10. Antigens of human pancreatic adenocarcinoma cells defined by murine monoclonal antibodies. Metzgar RS; Gaillard MT; Levine SJ; Tuck FL; Bossen EH; Borowitz MJ Cancer Res; 1982 Feb; 42(2):601-8. PubMed ID: 7034925 [TBL] [Abstract][Full Text] [Related]
11. High serum levels of DUPAN2 antigen and CA19-9 in pancreatic cancer: correlation with immunocytochemical localization of antigens in cancer cells. Suzuki Y; Ichihara T; Nakao A; Sakamoto J; Takagi H; Nagura H Hepatogastroenterology; 1988 Jun; 35(3):128-35. PubMed ID: 3042577 [TBL] [Abstract][Full Text] [Related]
12. Isolation and properties of a human pancreatic adenocarcinoma-associated antigen, DU-PAN-2. Lan MS; Finn OJ; Fernsten PD; Metzgar RS Cancer Res; 1985 Jan; 45(1):305-10. PubMed ID: 3965141 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical comparison of Lea, monosialosyl Lea (CA 19-9), and disialosyl Lea antigens in human colorectal and pancreatic tissues. Itzkowitz SH; Yuan M; Fukushi Y; Lee H; Shi ZR; Zurawski V; Hakomori S; Kim YS Cancer Res; 1988 Jul; 48(13):3834-42. PubMed ID: 3288336 [TBL] [Abstract][Full Text] [Related]
14. [Determination of serum DU-PAN-2 by enzyme immunoassay in patients with various digestive cancers]. Takemori Y; Sawabu N; Satomura Y; Ohta H; Watanabe H; Okai T; Mai M; Hattori N; Akiyama T; Hashimoto T Gan To Kagaku Ryoho; 1987 Jan; 14(1):119-26. PubMed ID: 3541791 [TBL] [Abstract][Full Text] [Related]
15. Clinical value of serum TAG-72 as a tumor marker for pancreatic carcinoma. Comparison with CA 19-9. Pasquali C; Sperti C; D'Andrea AA; Costantino V; Filipponi C; Pedrazzoli S Int J Pancreatol; 1994 Jun; 15(3):171-7. PubMed ID: 7930777 [TBL] [Abstract][Full Text] [Related]
16. Comparative studies on expression of CA 19-9 and DU-PAN-2 in pancreatic cancer tissue. Takasaki H; Uchida E; Tempero MA; Burnett DA; Metzgar RS; Pour PM Int J Pancreatol; 1987; 2(5-6):349-60. PubMed ID: 3320227 [TBL] [Abstract][Full Text] [Related]
17. [Diagnostic usefulness and limitation of measuring pancreatic cancer associate antigen, SPan-1, in patients with pancreatic cancer]. Satake K; Chung YS; Umeyama K; Takeuchi T; Kim YS Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1139-46. PubMed ID: 2730018 [TBL] [Abstract][Full Text] [Related]
18. Correlation between tumor-associated glycoprotein 72 mucin levels in tumor and serum of colorectal patients as measured by the quantitative CA 72-4 immunoassay. Guadagni F; Roselli M; Cosimelli M; Spila A; Cavaliere F; Tedesco M; Arcuri R; Abbolito MR; Casale V; Pericoli MN; Vecchione A; Casciani CU; Greiner JW; Schlom J Cancer Res; 1996 Nov; 56(22):5293-8. PubMed ID: 8912871 [TBL] [Abstract][Full Text] [Related]
19. [Carbohydrate antigen CA 19-9: value in pancreatic pathology]. Venot J; Vincent D; Gainant A; Descottes B; Cessot F; Beck C Gastroenterol Clin Biol; 1986 Mar; 10(3):208-10. PubMed ID: 3460925 [TBL] [Abstract][Full Text] [Related]
20. Carcinoembryonic antigen (CEA) and gastrointestinal cancer associated antigen CA 19-9 in bronchioloalveolar carcinomas and pulmonary adenocarcinomas. Heikkilä L; Suomalainen RJ; Lindgren J; Jalanko H; Harjula A; Mattila S Ann Chir Gynaecol; 1986; 75(5):260-5. PubMed ID: 3030184 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]